Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 4 1Phase 2/3 1

Status

Completed 19Recruiting 14Terminated 8Unknown 5Active not recruiting 4Withdrawn 2

Sponsor Class

OTHER 5

Study Type

Interventional 5

Sponsor

Cancer Type

Plasma cell 2Other hematologic neoplasm 2Lymphoid 2

Conditions

Multiple Myeloma 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Lymphoma 1Leukemia, Myeloid, Acute 1Hematologic Neoplasms 1

Interventions

Cisplatin 517Radiotherapy 378Cyclophosphamide 368Carboplatin 359Capecitabine 342Paclitaxel 337Oxaliplatin 336Gemcitabine 322Docetaxel 317Fluorouracil 291Drug Therapy 277Bevacizumab 249apatinib 247camrelizumab 219Etoposide 201Irinotecan 183Doxorubicin 181Leucovorin 164Dexamethasone 161pembrolizumab 155Neoadjuvant Therapy 146sintilimab 145anlotinib 140Blood Specimen Collection 140Pemetrexed 138Cytarabine 138toripalimab 133Surgical Procedures, Operative 131Radiosurgery 131S 1 (combination) 125

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Unknown × Hematopoietic Stem Cell Transplantation × Clear all
NCT01374841 2023-06-28

Hematopoietic Cell Transplantation for Patients With Hematologic Malignancies Using Related, HLA-Haploidentical Donors

European Institute of Oncology

Phase 2 Unknown
20 enrolled
Other hematologic neoplasm

Hematologic Neoplasms

NCT02605460 2020-01-14

Chemo Sensitization Before Hematopoietic Stem Cell Transplantation in Patients With Acute Leukemia in Complete Remission

Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran

Phase 2 Unknown
20 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT02929615 2016-10-12

Study of Standard and Individualized Treatment Model for Relapse and Refractory Lymphatic System Malignant Tumors

Peking University

Phase 4 Unknown
50 enrolled
Lymphoid

Lymphoma

NCT00415987 2008-06-20

Hematopoietic Stem Cell Transplantation in Myeloma

Azienda Ospedaliera San Giovanni Battista

Phase 2/3 Unknown
Plasma cell

Multiple Myeloma

NCT00702247 2008-06-20

Tandem Autologous- Nonmyeloablative Allogeneic Transplant for Newly Diagnosed Multiple Myeloma (Trapianto Tandem Autologo-Allogenico Non Mieloablativo Nel Mieloma Alla Diagnosi)

Azienda Ospedaliera San Giovanni Battista

Phase 2 Unknown
Plasma cell

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡